TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ).
Lumos Diagnostics Holdings Ltd has issued a total of 10,193,868 fully paid ordinary shares following the exercise of options by SBC Global Investment Fund and an employee. This issuance, conducted without disclosure under specific sections of the Corporations Act, signifies a strategic move to enhance the company’s capital structure, potentially impacting its market positioning and stakeholder interests.
More about Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics specializes in rapid, cost-effective point-of-care diagnostic test technology, assisting healthcare professionals in diagnosing and managing medical conditions. The company offers customized assay development, manufacturing services, and proprietary digital reader platforms, focusing on infectious and inflammatory diseases.
Average Trading Volume: 7,088,750
Technical Sentiment Signal: Buy
Current Market Cap: A$128M
See more data about LDX stock on TipRanks’ Stock Analysis page.